• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 10/01/14

    • 30-Day SEC Yield1

      -0.14%
    • Total Net Assets

      $531.6M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Key Points

    Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market cap and trading volume
    Industry Leaders 
    Index methodology favors the largest companies in the industry
    Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies allowing for enhanced industry representation
  • Trading Information

    • Fund Ticker

      BBH
    • Index Total Return Ticker

      MVBBHTR
    • NAV

      BBHNV
    • Intraday NAV (IIV)4

      BBHIV
    • Shares Outstanding

      5,096,503
    • Estimated Cash

      BBHEU
    • Total Cash

      BBHTC
    • CUSIP

      57060U183
    • ISIN

      US57060U1833
    Source: Bloomberg
  • Fees & Expenses2

    • Management Fee

      0.35%
    • Other Expenses

      0.06%
    • Gross Expense Ratio

      0.41%
    • Fee Waivers and
      Expense Reimbursement

      -0.06%
    • Net Expense Ratio/TER2

      0.35%
    2 Expenses for BBH are capped contractually at 0.35% until at least 2/01/15. TER, or Total Expense Ratio, is also referred to as "Net Expense Ratio". Cap excludes certain expenses, such as interest.
  • Prices as of 10/01/2014

    NAV/
    Last Price
    Volume
    30-Day Avg./
    Last Trading Day
    Daily Change
    NAV/
    Last Price
    YTD Change
    NAV/
    Last Price
    Premium/
    Discount
    Prem/Discount
    Distribution Charts
    NAV &
    Prem/Discount
    History
    NAV
    Chart
    BBH $104.30
    $104.31
    84,315
    144,349
    $-1.54 / -1.46%
    $-1.53 / -1.45%
    + 17.8%
    + 17.8%

    $0.01
    0.01%
  • View All Indices » View All ETFs » Performance History: Average Annual Total Returns* (%)

    1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR LIFE
    12/20/11
    BBH (NAV) 10.57 18.19 20.98 38.15 -- -- -- 51.09
    BBH (Share Price) 10.55 18.14 20.94 38.08 -- -- -- 51.13
    MVBBHTR (Index) 10.60 18.28 21.15 38.36 45.90 -- -- 51.40
    Performance Differential (NAV - Index) -0.03 -0.09 -0.17 -0.21 -- -- -- -0.31
    1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR LIFE
    12/20/11
    BBH (NAV) 5.29 4.92 7.77 39.38 -- -- -- 48.40
    BBH (Share Price) 5.25 4.88 7.75 39.23 -- -- -- 48.44
    MVBBHTR (Index) 5.31 4.99 7.87 39.53 -- -- -- 48.69
    Performance Differential (NAV - Index) -0.02 -0.07 -0.10 -0.15 -- -- -- -0.29
  • View All Holdings »Top 10 Holdings (%)as of 08/31/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    849,942
    91,436,76016.75
    Amgen Inc
    AMGN US
    462,115
    64,409,58911.80
    Celgene Corp
    CELG US
    580,111
    55,122,14710.10
    Biogen Idec Inc
    BIIB US
    146,726
    50,332,8879.22
    Vertex Pharmaceuticals Inc
    VRTX US
    289,925
    27,128,2824.97
    Regeneron Pharmaceuticals Inc
    REGN US
    69,230
    24,266,5004.45
    Alexion Pharmaceuticals Inc
    ALXN US
    142,507
    24,125,0104.42
    Illumina Inc
    ILMN US
    121,069
    21,714,9363.98
    Pharmacyclics Inc
    PCYC US
    154,207
    19,181,8093.51
    Biomarin Pharmaceutical Inc
    BMRN US
    264,328
    18,825,4403.45
    Top 10 Total (%)72.65
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.
  • Country Weightings (%)
    as of 08/31/14

    • Country

      % of Net Assets
    • U.S.

      96.5
    • NETHERLANDS

      3.4
    • Other

      0.1
  • Sector Weightings (%)
    as of 08/31/14

    • Sector

      % of Net Assets
    • Health Care

      99.9
    • Other

      0.1